BofA/Merrill Lynch Downgrades Novartis (NVS) to Neutral
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $153.37 --0%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 1
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 1
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Novartis (NYSE: NVS) from Buy to Neutral.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Papa John\'s (PZZA) to Underperform, 'Management turnover increases NT uncertainty'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
- Krystal Biotech (KRYS) PT Raised to $396 at BofA Securities
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
